DUBLIN, Sept. 28, 2018 /PRNewswire/ --
The "PDX Models: The North American Market to 2025 with Analysis on Type, Tumor Type, Application, End-User and Geography" report has been added to ResearchAndMarkets.com's offering.
The North America PDX models market is expected to hold the leading market share during the forecast period of 2018 to 2025.
Prominent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization.
The North America PDX models market is segmented based on type into two notable segments; mice models and rat models. In 2018, mice models segment is valued to rule with the highest market share by 2025.
The North America PDX models market is segmented in tumor type categories into six notable segments; respiratory tumor models, urological tumor models, gastrointestinal tumor models, hematological tumor models, gynecological tumor models and others. In 2018, respiratory tumor models segment is valued to rule with the highest market shares by 2025, rising at the highest CAGR.
The North America PDX models market is segmented in application into preclinical drug development and oncology research and biomarker analysis. In 2018, preclinical drug development and oncology research segment is valued to rule with highest market shares and rising at the highest CAGR.
The North America PDX models market is segmented in end user into contract research organization (CRO), academic and research institutions and pharmaceutical and biotechnology companies. In 2018, contract research organization (CRO) segment is valued to rule with highest market shares and rising at the highest CAGR.
- Crown Bioscience Inc.
- The Jackson Laboratory
- Champion Oncology Inc.
- Charles River
- Wuxi AppTec
- Horizon Discovery Group plc
- Pharmatest Services
- Hera Biolabs
- EPO Berlin-Buch GmbH
- Creative Animodel
- MI Bioresearch Inc.
- Aragen Bioscience
Key Topics Covered
1.1 Objectives of the Study
1.2 Market Definition
1.3 Overview of North America PDX Models Market
1.4 Currency and Pricing
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographic Scope
2.3 Years Considered For the Study
2.4 Currency and Pricing
2.5 Research Methodology
2.6 Primary Interviews With Key Opinion Leaders
2.7 Secondary Sources
3 Market Overview
4 Executive Summary
5 Premium Insights
6 North America PDX Models Market, by Type
6.2 Mice Models
6.3 Rat Models
7 North America PDX Models Market, by Tumor Type
7.2 Gastrointestinal Tumor Models
7.3 Gynecological Tumor Models
7.4 Respiratory Tumor Models
7.5 Urological Tumor Models
7.6 Hematological Tumor Models
8 North America PDX Models Market, by Application
8.2 Preclinical Drug Development and Oncology Research
8.3 Biomarker Analysis
9 North America PDX Models Market, by End-User
9.2 Contract Research Organizations
9.3 Pharmaceutical and Biotechnology Companies
9.4 Academic and Research Institutions
10 North America PDX Models Market, by Geography
10.1 North America
11 North America PDX Models Market, Company Landscape
11.1 Company Share Analysis: North America
12 Company Profiles
12.1 Charles River
12.2 Crown Bioscience Inc. (Subsidiary of JSR Corporation)
12.3 Champion Oncology Inc.
12.4 Aragen Bioscience (Subsidiary of GVK Biosciences Private Limited)
12.5 Creative Animodel
12.6 Epo Berlin-Buch GmbH
12.8 Hera Biolabs
12.9 Horizon Discovery Group PLC
12.10 Mi Bioresearch Inc.
12.12 Pharmatest Services Ltd.
12.13 the Jackson Laboratory
12.15 Wuxi Apptec
For more information about this report visit https://www.researchandmarkets.com/research/k8dz9k/pdx_models_the?w=5
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets